Atherosclerosis

In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.

CT imaging of patients entering lung cancer treatment identified a high prevalence of atherosclerosis, according to data presented at the American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient course.

SARS-CoV-2 infection was associated with more rapid coronary plaque progression and significantly increased risk for adverse outcomes related to target lesion failure, such as heart attack and death, researchers reported.

A study found patients treated with interleukin inhibitors did not experience a difference in the rates of major adverse cardiovascular and venous thromboembolic events compared with those treated with tumor necrosis factor inhibitors.

Women with menopause onset before age 45 years were more likely to develop incident heart failure regardless of serum adipokine levels, according to study findings published in Menopause.

For nearly 2 decades, George L. Bakris, MD, was a pillar of the Cardiometabolic Health Congress, sharing his expertise, passion and unwavering dedication to advancing cardiometabolic health.

The Cardiometabolic Health Congress announced that Peter Libby, MD, one of the foremost authorities in atherosclerosis, will deliver the keynote address at its upcoming 19th annual conference.

An estimated 16 million U.S. adults who qualified for statin and/or antihypertensive therapy would not be eligible for primary prevention under the American Heart Association’s new PREVENT risk calculator, researchers reported in JAMA.

With the use of AI-enabled quantitative coronary plaque analysis, researchers developed nomograms designed to improve risk stratification of patients who may be at risk for atherosclerosis.